Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 13,250 KRW
Change Today +1,700 / 14.72%
Volume 4.9M
000250 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:25 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

sam chun dang pharm co ltd (000250) Snapshot

Open
12,500
Previous Close
11,550
Day High
14,150
Day Low
12,350
52 Week High
07/3/15 - 14,150
52 Week Low
09/1/14 - 7,990
Market Cap
279.0B
Average Volume 10 Days
1.1M
EPS TTM
537.00
Shares Outstanding
21.1M
EX-Date
12/29/14
P/E TM
24.7x
Dividend
75.00
Dividend Yield
0.57%
Current Stock Chart for SAM CHUN DANG PHARM CO LTD (000250)

Related News

No related news articles were found.

sam chun dang pharm co ltd (000250) Related Businessweek News

No Related Businessweek News Found

sam chun dang pharm co ltd (000250) Details

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceutical products primarily in South Korea. It offers products in the areas of ophthalmology, cardiovascular, endocrinology, gastrointestine, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, musculoskeletal, and vitamins. The company was founded in 1943 and is headquartered in Seoul, South Korea.

Founded in 1943

sam chun dang pharm co ltd (000250) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sam chun dang pharm co ltd (000250) Key Developments

Sam Chun Dang Pharm. Co.,Ltd, Annual General Meeting, Mar 30, 2015

Sam Chun Dang Pharm. Co.,Ltd, Annual General Meeting, Mar 30, 2015., at 09:00 Korea Standard Time. Location: Hwaseong hyangnameup administration three road 50 (Haengjeongri, 437-3). Agenda: To consider the financial statements and the consolidated financial statements; to consider the appointment of directors; to consider the appointment of inside directors night the whole school; to consider the appointment of inside directors; to consider the appointment of outside directors; and to consider the approval of director remuneration.

Sam Chun Dang Pharm. Co.,Ltd, Annual General Meeting, Mar 14, 2014

Sam Chun Dang Pharm. Co.,Ltd, Annual General Meeting, Mar 14, 2014., at 09:00 Korea Standard Time. Location: Social Welfare Center 3rd Floor Auditorium Southern Hwaseong. Agenda: To consider the audit report; to consider the business report; to consider the approval of the financial statements and in the consolidated financial statements; to consider the approval of director remuneration; and to consider the other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000250:KS 13,250.00 KRW +1,700

000250 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000250.
View Industry Companies
 

Industry Analysis

000250

Industry Average

Valuation 000250 Industry Range
Price/Earnings 25.3x
Price/Sales 2.1x
Price/Book 2.5x
Price/Cash Flow 24.8x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAM CHUN DANG PHARM CO LTD, please visit www.scd.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.